The World Health Organization defines osteoporosis as a bone mineral density 2.5 or more standard deviations below peak bone mass of the twenty-year-old healthy female average. Morbidity and mortality rates are significant in osteoporosis. One of the greatest concerns is a hip fracture in which around 13.5% of people die within six months and another 13% cannot mobilize without assistance. The underlying mechanism is an imbalance between bone resorption (osteoclast activity) and bone formation (osteoblast activity).
Hypercholesterolemia is a collective term reflecting high levels of cholesterol in the blood. It in itself, is not the disease, but is a major underlying cause of cardiovascular disease. Heart disease/cardiovascular disease is the number one killer in the United States at 652,091 deaths per year. Elevated cholesterol is due to abnormalities in the levels of lipoproteins in the blood. The type of hypercholesterolemia depends on which type of lipoprotein is in excess with Type IIa and Type IIb being the most common.
Let’s start with the facts. As of the latest information available from the National Center for Health Statistics, cancer is the number two leading cause of death in the U.S. per year at 559,312. Heart disease is number one at 652,091, while stroke is at a distant number three at 143,579; followed by chronic lower respiratory diseases, accidents, diabetes, Alzheimers, influenza/pneumonia, nephritis/nephrotic syndrome/nephrosis and septicemia.1
Why does it seem so elusive to get straight answers about bio-identical hormones? Bio-identical hormones consist of a combination of some or all of the following: Estrone, estradiol, estriol, progesterone, testosterone, dehydroepiandrosterone, hydrocortisone, levothyroxine and liothyronine. A successful bio-identical hormone replacement regimen consists of a balance incorporating family and personal history, side effects, dosage form preference and clinical response.